About Our Program

As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.

Featured Scientist

Dr. Corinna Koebnick headshot
Corinna Koebnick, PhD, MSc
Research Scientist II
Division of Behavioral Resarch
626-564-3693
Corinna.Koebnick@kp.org

Dr. Corinna Koebnick is a nutrition scientist and obesity researcher whose work focuses on the prevention and treatment of obesity in children, adolescents, and young adults. Her research examines critical issues such as the health consequences of obesity. She also studies ways to optimize the health services provided to individuals with obesity.

Dr. Koebnick pursues a strong interest in molecular epidemiology. She is currently investigating the interactions between diet and adipokines. ...

Featured Video

Advancing treatments through clinical trials

Over the years, clinical trials have led to amazing advances in treatment—even cures—for devastating illnesses. William Towner, MD, FACP, FIDSA, regional physician director for clinical trials, describes how trials at Kaiser Permanente contribute to the development of more effective and safer treatments for diseases such as HIV, hepatitis C, cancer, and more. (2:15)

News

Featured Image of News Story Titled: Five questions for … Dr. Sarah Carter

Five questions for … Dr. Sarah Carter

Sarah Carter, DPhil, MA, is a post-doctoral research fellow at Kaiser Permanente Southern California’s Department of Research & Evaluation. She completed her doctoral work at the University of Southampton in England, where she studied childbirth intervention in the United Kingdom’s National Health Service (NHS). She is currently studying pre- and perinatal maternal health, environmental exposures, ...

Vulnerable populations sought virtual care during pandemic

Kaiser Permanente Southern California patients who were Latinx or low-income had the largest percentage increase in use of telehealth during the COVID-19 pandemic, according to Kaiser Permanente research recently published in Journal of Medical Internet Research.  Increases in telehealth visits during the COVID-19 pandemic varied across age, sex, race/ethnicity, and household income groups, while decreases ...

Infant lung disease rates drop dramatically over 10-year effort

Over the last decade, rates of a chronic lung condition known as bronchopulmonary dysplasia have dropped from 20% to less than 2% among very preterm babies at Kaiser Permanente Panorama City. As reported in JAMA Network Open, this decrease is associated with a novel system of care designed by Kaiser Permanente Southern California researchers. Meanwhile, ...

Young children gained weight during the pandemic

A Kaiser Permanente study of nearly 200,000 children showed that children gained excess weight during the COVID-19 pandemic, especially those between 5 and 11 years old. The study was published in the Journal of the American Medical Association. “When we compared the weight gain among children from 2019 to 2020, we found that there was ...

5 questions for … Dr. Darryl Palmer-Toy

Darryl Palmer-Toy, MD, PhD, is the physician director of the Regional Reference Core Laboratories for Kaiser Permanente Southern California. He has been in this position for 5 years. In this role, Dr. Palmer-Toy oversees the ancillary, clinical chemistry, and immunochemistry departments, which perform about 20 million tests per year. A student of proteomics (the study ...

Events

Featured Division

Clinical Trials Research

Our physician investigators conduct clinical trials in communities across Southern California, from Bakersfield to San Diego.

The Division of Clinical Trials Research advances medical innovation by supporting evaluation of new drugs, therapies, and devices to prevent and treat health problems. Our physician investigators work with cooperative groups and industry sponsors to conduct clinical trials for investigational drugs, biologics, and devices. In addition, the division develops pragmatic trials that help answer questions about care delivery.

The region has clinical trials programs in oncology (adult, gynecologic, pediatric, and surgical/radiation oncology), urology, gynecology, neurology, dermatology, metabolic diseases, nephrology, ophthalmology, infectious disease, cardiology, hepatology, vascular surgery, and rheumatology. Clinical trials staff support trials at medical centers and medical office buildings throughout the Kaiser Permanente Southern California Region.